These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24756719)

  • 1. TRPM6.
    Chubanov V; Gudermann T
    Handb Exp Pharmacol; 2014; 222():503-20. PubMed ID: 24756719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPM1.
    Irie S; Furukawa T
    Handb Exp Pharmacol; 2014; 222():387-402. PubMed ID: 24756714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPM8.
    Almaraz L; Manenschijn JA; de la Peña E; Viana F
    Handb Exp Pharmacol; 2014; 222():547-79. PubMed ID: 24756721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPM7.
    Fleig A; Chubanov V
    Handb Exp Pharmacol; 2014; 222():521-46. PubMed ID: 24756720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPM2.
    Faouzi M; Penner R
    Handb Exp Pharmacol; 2014; 222():403-26. PubMed ID: 24756715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RACK1 inhibits TRPM6 activity via phosphorylation of the fused alpha-kinase domain.
    Cao G; Thébault S; van der Wijst J; van der Kemp A; Lasonder E; Bindels RJ; Hoenderop JG
    Curr Biol; 2008 Feb; 18(3):168-76. PubMed ID: 18258429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPM4.
    Mathar I; Jacobs G; Kecskes M; Menigoz A; Philippaert K; Vennekens R
    Handb Exp Pharmacol; 2014; 222():461-87. PubMed ID: 24756717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family.
    Schlingmann KP; Weber S; Peters M; Niemann Nejsum L; Vitzthum H; Klingel K; Kratz M; Haddad E; Ristoff E; Dinour D; Syrrou M; Nielsen S; Sassen M; Waldegger S; Seyberth HW; Konrad M
    Nat Genet; 2002 Jun; 31(2):166-70. PubMed ID: 12032568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPM6: A Janus-like protein.
    Bödding M
    Handb Exp Pharmacol; 2007; (179):299-311. PubMed ID: 17217065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPM3.
    Oberwinkler J; Philipp SE
    Handb Exp Pharmacol; 2014; 222():427-59. PubMed ID: 24756716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinase and channel activity of TRPM6 are co-ordinated by a dimerization motif and pocket interaction.
    van der Wijst J; Blanchard MG; Woodroof HI; Macartney TJ; Gourlay R; Hoenderop JG; Bindels RJ; Alessi DR
    Biochem J; 2014 Jun; 460(2):165-75. PubMed ID: 24650431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 4,5-bisphosphate (PIP(2)) controls magnesium gatekeeper TRPM6 activity.
    Xie J; Sun B; Du J; Yang W; Chen HC; Overton JD; Runnels LW; Yue L
    Sci Rep; 2011; 1():146. PubMed ID: 22180838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens.
    Groenestege WM; Hoenderop JG; van den Heuvel L; Knoers N; Bindels RJ
    J Am Soc Nephrol; 2006 Apr; 17(4):1035-43. PubMed ID: 16524949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPM6 kinase activity regulates TRPM7 trafficking and inhibits cellular growth under hypomagnesic conditions.
    Brandao K; Deason-Towne F; Zhao X; Perraud AL; Schmitz C
    Cell Mol Life Sci; 2014 Dec; 71(24):4853-67. PubMed ID: 24858416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7.
    Li M; Jiang J; Yue L
    J Gen Physiol; 2006 May; 127(5):525-37. PubMed ID: 16636202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TRPM6 kinase domain determines the Mg·ATP sensitivity of TRPM7/M6 heteromeric ion channels.
    Zhang Z; Yu H; Huang J; Faouzi M; Schmitz C; Penner R; Fleig A
    J Biol Chem; 2014 Feb; 289(8):5217-27. PubMed ID: 24385424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New TRPM6 missense mutations linked to hypomagnesemia with secondary hypocalcemia.
    Lainez S; Schlingmann KP; van der Wijst J; Dworniczak B; van Zeeland F; Konrad M; Bindels RJ; Hoenderop JG
    Eur J Hum Genet; 2014 Apr; 22(4):497-504. PubMed ID: 23942199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice defective in Trpm6 show embryonic mortality and neural tube defects.
    Walder RY; Yang B; Stokes JB; Kirby PA; Cao X; Shi P; Searby CC; Husted RF; Sheffield VC
    Hum Mol Genet; 2009 Nov; 18(22):4367-75. PubMed ID: 19692351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia.
    Schlingmann KP; Sassen MC; Weber S; Pechmann U; Kusch K; Pelken L; Lotan D; Syrrou M; Prebble JJ; Cole DE; Metzger DL; Rahman S; Tajima T; Shu SG; Waldegger S; Seyberth HW; Konrad M
    J Am Soc Nephrol; 2005 Oct; 16(10):3061-9. PubMed ID: 16107578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient receptor potential melastatin 6 knockout mice are lethal whereas heterozygous deletion results in mild hypomagnesemia.
    Woudenberg-Vrenken TE; Sukinta A; van der Kemp AW; Bindels RJ; Hoenderop JG
    Nephron Physiol; 2011; 117(2):p11-9. PubMed ID: 20814221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.